Rosenberg Paul A, Amin Ketan G, Zibari Yigal, Lin Louis M
Postgraduate Endodontic Program, Department of Endodontics, New York University College of Dentistry, 345 East 24th Street, New York, NY 10010, USA.
J Endod. 2007 Apr;33(4):403-5. doi: 10.1016/j.joen.2006.11.019. Epub 2007 Feb 20.
A randomized, double-blind trial was conducted to compare the efficacy of 4% articaine with 1:100,000 epinephrine and 2% lidocaine with 1:100,000 epinephrine when used as a supplemental anesthetic. Forty-eight patients with irreversible pulpitis requiring supplemental buccal infiltration for endodontic therapy were given either 4% articaine with 1:100,000 epinephrine or 2% lidocaine with 1:100,000 epinephrine in a double-blind manner. A standard VAS pain scale was used to evaluate the patient's response to pain after a supplemental injection. The mean VAS score after supplemental anesthesia was 15.28 for 4% articaine with 1:100,000 epinephrine and 19.70 for 2% lidocaine with 1:00,000 epinephrine. The mean percentage change in VAS score was 70.5 and 62.2% for articaine and lidocaine, respectively. There was no statistically significant difference in the VAS pain score between 4% articaine with 1:00,000 epinephrine and 2% lidocaine with 1:00,000 epinephrine as a supplemental anesthetic.
进行了一项随机双盲试验,以比较4%阿替卡因加1:100,000肾上腺素和2%利多卡因加1:100,000肾上腺素作为补充麻醉剂时的疗效。48例需要进行牙髓治疗且需补充颊侧浸润麻醉的不可逆性牙髓炎患者,以双盲方式分别给予4%阿替卡因加1:100,000肾上腺素或2%利多卡因加1:100,000肾上腺素。采用标准视觉模拟评分法(VAS)评估补充注射后患者对疼痛的反应。补充麻醉后,4%阿替卡因加1:100,000肾上腺素组的平均VAS评分为15.28,2%利多卡因加1:100,000肾上腺素组为19.70。阿替卡因和利多卡因组VAS评分的平均变化百分比分别为70.5%和62.2%。作为补充麻醉剂,4%阿替卡因加1:100,000肾上腺素和2%利多卡因加1:100,000肾上腺素之间的VAS疼痛评分无统计学显著差异。